207
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Chronic Limb-Threatening Ischemia in Patients with Type 2 Diabetes: Revascularization Index as a Predictor for Primary Endovascular Intervention Outcome

, , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 495-504 | Received 04 Nov 2022, Accepted 21 Jun 2023, Published online: 31 Jul 2023

References

  • Song P, Rudan D, Zhu Y, et al. Global, regional and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020–e1030. doi:10.1016/S2214-109X(19)30255-4
  • Chase-Vilchez AZ, Chan IHY, Sanne AE, Peters SAP, Woodward M. Diabetes as a risk factor for incident peripheral arterial disease in women compared to men: a systematic review and meta-analysis. Cardiovasc Diabetol. 2020;19:151.
  • Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. 2004;116(4):236–240. doi:10.1016/j.amjmed.2003.09.038
  • Marso SP, Hiatt WR. Peripheral arterial disease in diabetic patients. J Am Coll Cardiol. 2006;47(5):921–929. doi:10.1016/j.jacc.2005.09.065
  • Davies MG. Critical limb ischemia: epidemiology. Methodist DebakeyCardiovasc J. 2012;8(4):10‐14.
  • Hardman RL, Jazaeri O, Yi J, Smith M, Gupta R. Overview of classification systems in peripheral artery disease. SeminIntervent Radiol. 2014;31(4):378–388.
  • Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1):s109–s133.
  • Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808–1817. doi:10.1161/ATVBAHA.120.314595
  • Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009;301(4):415–424. doi:10.1001/jama.301.4.415
  • Firnhaber J, Powell CS. Lower extremity peripheral artery disease diagnosis and treatment. Am Fam Physician. 2019;99(6):362–369.
  • Topfer LA, Spry C. New technologies for the treatment of peripheral artery disease. 2018 April 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016:172. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519606/. Accessed July 13, 2023.
  • Kinlay S. Management of Chronic limb-threatening ischemia. Circ Cardiovasc Interv. 2016;9(2):e001946.
  • Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686–e725. doi:10.1161/CIR.0000000000000470
  • Van den Berg JC. Angiosome perfusion of the foot: an old theory or a new issue? Semin Vasc Surg. 2018;31(2–4):56–65. doi:10.1053/j.semvascsurg.2018.12.002
  • Biagioni RB, Biagioni LC, Nasser F, et al. Infra popliteal angioplasty of one or more than one artery for critical limb ischemia: a randomized clinical trial. Eur J Vasc Endo Vascular Surg. 2018;55(4):518–527. doi:10.1016/j.ejvs.2017.12.022
  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67. doi:10.1016/j.jvs.2006.12.037
  • Bollinger A, Breddin K, Hess H, et al. Semi quantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis. 1981;38(3–4):339–346. doi:10.1016/0021-9150(81)90050-2
  • Cerqueira LO, Duarte Júnior EG, Barros ALS, Cerqueira JR, Araújo WJB. WIfI classification: the Society for Vascular Surgery lower extremity threatened limb classification system, a literature review. J Vasc Bras. 2020;19:e20190070. doi:10.1590/1677-5449.190070
  • Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220–234.e1–2.
  • Srivaratharajan K, Abramason B. Women and peripheral arterial disease: a review of sex differences in epidemiology, clinical manifestations and outcome. Can J Cardiol. 2018;34:356–361.
  • Stefanska A, Sypniewskay G, Senterkiewicz L. Inflammatory markers and cardiovascular risk in healthy Polish women across the menopausal transition. Clin Chem. 2005;51(10):1893–1895. doi:10.1373/clinchem.2005.052191
  • Teodorescu VJ, Vavra AK, Kibbe MR. Peripheral arterial disease in women. J Vasc Surg. 2013;57(4):18s–26s. doi:10.1016/j.jvs.2012.10.115
  • Lu JT, Creager MA. The relationship of cigarette smoking to peripheral arterial disease. Rev Cardiovasc Med. 2004;5(4):189–193.
  • Liu M, Zhang W, Yan Z, Yuan X. Smoking increase the risk of diabetic foot amputation: a meta-analysis. ExpTher Med. 2018;15(2):1680–1685.
  • Gilhotra RA, Rodrigues BT, Vangaveti VN, Malabu UH. Prevalence and risk factors of lower limb amputation in patients with end-stage renal failure on dialysis: a systematic review. Int J Nephrol. 2016;ID 4870749:7. doi:10.1155/2016/4870749
  • Meloni M, Izzo V, Giurato L, et al. Recurrence of chronic limb-threatening ischemia after endovascular intervention in patients with diabetic foot ulcers. Adv Wound Care. 2018;7(6):171–176. doi:10.1089/wound.2017.0778
  • Darling JD, McCallum JC, Soden PA, et al. Predictive ability of the SVS WIfI classification system following first-time lower extremity revascularizations. J Vasc Surg. 2017;65(3):695–704. doi:10.1016/j.jvs.2016.09.055
  • Aboyansa V, Riccoa J-B, Bartelinka MLEL. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:305–368.
  • Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961–969. doi:10.4239/wjd.v6.i7.961
  • Gutierrez MI, Vicente S, Criado F, et al. Below-the-Knee revascularization of critical limb ischemia in diabetic patients. Vasc Dis Manag. 2020;17(7):e150–e154.
  • Meecham L, Bate G, Patel S, Bradbury AWA. Comparison of clinical outcomes following femoropopliteal bypass or plain balloon angioplasty with selective bare metal stenting in the bypass versus angioplasty in severe ischemia of the limb (BASIL). Trial Eur J Vasc Endovasc Surg. 2019;58:52–59.
  • Biscetti F, Nardella E, Rando MM, et al. Review outcomes of lower extremity endovascular revascularization: potential predictors and prevention strategies. Int J Mol Sci. 2021;2002. doi:10.3390/ijms22042002
  • Faglia E, Paola LD, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29(6):620–627. doi:10.1016/j.ejvs.2005.02.035
  • Spreen MI, Martens JM, Hansen BE, et al. Percutaneous transluminal angioplasty and drug eluting stents for infrapopliteal lesions in critical limb ischemia (PADI) trial. Circ Cardiovasc Interv. 2016;9(2):e002376. doi:10.1161/CIRCINTERVENTIONS.114.002376
  • Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of chronic limb-threatening ischemia: a review of recent literature. Vasc Health Risk Manag. 2019;15:187–208. doi:10.2147/VHRM.S209241
  • Sumpio BE, Forsythe RO, Ziegler KR, van Baal JG, Lepantalo MJA, Hinchliffe RJ. Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg. 2013;58(3):814–826. doi:10.1016/j.jvs.2013.06.056
  • Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581. doi:10.1001/jama.287.19.2570
  • Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and Clinical applications. Br J Plast Surg. 1987;40(2):113–141. doi:10.1016/0007-1226(87)90185-8
  • Attinger CE, Evans KK, Bulan E, Blume P, Cooper P. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg. 2006;117(suppl 7):261S–293S. doi:10.1097/01.prs.0000222582.84385.54
  • Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R. Critical limb ischemia: current challenges and future prospects. Vasc Health Risk Manag. 2018;2018:14 63–74.
  • Biancari F, Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J VascEndovasc Surg. 2014;47(5):517–522. doi:10.1016/j.ejvs.2013.12.010
  • Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305–2316. doi:10.1056/NEJMoa2207899
  • ShKabra A, Suresh KR, Vivekanand V. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg. 2013;57(1):44–49. doi:10.1016/j.jvs.2012.07.042
  • Faglia E, Clerici G, Scatena A, et al. Severity of demographic and clinical characteristics, revascularization feasibility, major amputation, and mortality rate in diabetic patients admitted to a tertiary diabetic foot center for critical limb ischemia: comparison of 2 cohorts recruited at a 10-year distance. Ann Vas Surg. 2014;28(7):1729–1736.
  • Uccioli L, Gandini R, Giurato L, et al. Long-term outcomes of diabetic patients with critical limb ischemia in diabetic foot patients followed in a tertiary referral diabetic foot clinic. Diabetes Care. 2010;33(5):977–982. doi:10.2337/dc09-0831